Mark Ebert
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
-
- Breast Lesions and Carcinomas
Papers in
-
- Breast Cancer Treatment Studies 10
- Oncology 4
- Co-authors
- Charles E. Cox (11 shared papers)Alan Cantor (9 shared papers)Douglas S. Reintgen (7 shared papers)Elisabeth Dupont (10 shared papers)Eric Peltz (4 shared papers)Keoni Nguyen (4 shared papers)Sheila Sheth (2 shared papers)Elliot K. Fishman (2 shared papers)
- Journals
- The American Journal of Surgery (4 papers)Annals of Surgical Oncology (3 papers)Annals of Surgery (2 papers)Journal of the American Medical Informatics Association (1 paper)Journal of the American College of Surgeons (1 paper)
- Partner nations
- United StatesGermanyAustria
In The Last Decade
Mark Ebert
24 papers receiving 733 citations
Peers
Comparison fields: 5 of 92
- Cancer Research 417
- Pathology and Forensic Medicine 210
- Internal Medicine 23
- Surgery 241
- Oncology 111
Countries citing papers authored by Mark Ebert
This map shows the geographic impact of Mark Ebert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Ebert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Ebert more than expected).
Fields of papers citing papers by Mark Ebert
This network shows the impact of papers produced by Mark Ebert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Ebert. The network helps show where Mark Ebert may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Ebert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 133 | |
| 2 | 2002 | 111 | |
| 3 | 2004 | 71 | |
| 4 | 2010 | 64 | |
| 5 | 2003 | 54 | |
| 6 | 2001 | 47 | |
| 7 | 2002 | 45 | |
| 8 | 2004 | 45 | |
| 9 | 2004 | 44 | |
| 10 | 2001 | 36 | |
| 11 | 2013 | 35 | |
| 12 | 2008 | 16 | |
| 13 | 2003 | 15 | |
| 14 | 2019 | 12 | |
| 15 | 2004 | 9 | |
| 16 | 2012 | 9 | |
| 17 | 2011 | 8 | |
| 18 | 2003 | 7 | |
| 19 | 2003 | 6 | |
| 20 | Evaluation von Synergien bei Unternehmenszusammenschlüssen | 1998 | 3 |
About Mark Ebert
Mark Ebert is a scholar working on Cancer Research, Oncology, Surgery, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging, having authored 24 papers that have together received 775 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (10 papers), Breast Lesions and Carcinomas (3 papers), Breast Implant and Reconstruction (2 papers), Multiple and Secondary Primary Cancers (1 paper), Fetal and Pediatric Neurological Disorders (1 paper), Venous Thromboembolism Diagnosis and Management (1 paper), AI-based Problem Solving and Planning (1 paper) and Radiation Therapy and Dosimetry (1 paper). The work is most often cited by research in Cancer Research (417 citations), Pathology and Forensic Medicine (210 citations), Internal Medicine (23 citations), Surgery (241 citations) and Oncology (111 citations). Mark Ebert has collaborated with scholars based in United States, Germany and Austria. Frequent co-authors include Charles E. Cox, Alan Cantor, Douglas S. Reintgen, Elisabeth Dupont, Eric Peltz, Keoni Nguyen, Sheila Sheth, Elliot K. Fishman, Alan R. Shons and Christopher Salud. Their work appears in journals such as The American Journal of Surgery, Annals of Surgical Oncology, Annals of Surgery, Journal of the American Medical Informatics Association and Journal of the American College of Surgeons.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.